Latest News
Push for more NHS organisations to get involved in clinical research
There is hope that everyone in the UK's National Health Service (NHS) to get involved in clinical research, said professor…
FibroGen’s pamrevlumab disappointing results marks second failure in a row
FibroGen’s lead candidate pamrevlumab failed to meet its primary and secondary endpoints in the Phase III trial in ambulatory Duchenne…
Regeneron partners with US Government to develop Covid-19 antibody vaccine
US-based Biomedical Advanced Research and Development Authority (BARDA) has partnered with Regeneron on the Covid-19 monoclonal antibody vaccine clinical development…
Ocugen plans Phase I/II trials for macular disease gene therapies
Phase I/II trials for Ocugen’s gene therapies, OCU410 and OCU410ST, are planned for initiation by the end of 2023 in…
Exelixis and Ipsen to seek approval for Cabometyx in prostate cancer
The Phase III trial investigating the combination treatment of Exelixis and Ipsen’s Cabometyx (cabozantinib) and Roche’s Tecentriq (atezolizumab) as a…